Ireland boosts throughput in key long-wait procedures
This article was originally published in Clinica
Ireland has approved a programme of pilot projects to increase throughput in surgical procedures that are subject to long waits. Euro2.5m ($3.2m) has been allocated to provide urgent access to a consultant in each of the 14 key specialties covered by the National Treatment Purchase Fund (NTPF). Where necessary, the NTPF, with a 2005 budget of Euro64m (up from Euro44m last year), will then fund the procedure. The NTPF sources this work primarily from Irish hospitals; where necessary, it will also use the private sector in Northern Ireland and Great Britain.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.